There were 462 press releases posted in the last 24 hours and 100,643 in the last 365 days.

Liquid Embolic Market To Reach USD 3.27 Billion By 2027 With CAGR of 9.2% | Reports And Data

Reports And Data

Reports And Data

The paradigm shift from clipping to coiling and increased demand for minimally invasive surgeries has augmented the demand for the market.

NEW YORK, NY, UNITED STATES, November 6, 2021 /EINPresswire.com/ -- The global Liquid Embolic market is forecast to reach USD 3.27 Billion by 2027, according to a new report by Reports and Data. Embolization is a minimally invasive, non-surgical procedure that involves the selective occlusion of blood vessels, by purposely introducing emboli. The procedure is an alternative to open surgery and is performed by interventional neuroradiologists. Liquid embolic products are used for the embolization of both arterio-venous malformations (AVMs) and aneurysms.

Liquid embolic agents include ethylene vinyl alcohol and cyanoacrylate. These agents are used to prevent blood supply to aneurysm or tumor. It helps in suppressing the growth and any adverse effects suffered by aneurysms and tumors to vital organs. Liquid embolic agents have the advantage over the flexibility and expense, as well as the threat of vascular injury during navigation. The market is expected to grow due to the increasing adoption of liquid embolic agents due to the favorable clinical research results. The growing prevalence of arteriovenous malformation, growth in the incidence of tumors, and aneurysms factors are also driving the growth of the market.

However, liquid embolic agents are not compatible with everyone, and there lies a potential risk in embolization of untargeted blood cells. This may limit the market growth. Moreover, insufficient supply and shortage of manufacturers are also factors hindering the growth of the market.

To Gain Access to an all-inclusive PDF Sample Report, Click Here: https://www.reportsanddata.com/sample-enquiry-form/2690

Leading companies operating in the market and profiled in the report include:

Medtronic, Cyberonics, InoMed, Boston Scientific, Codman, and Shurtleff. RauMedic, St. Jude Medical, Stryker, Mizuho America, and Integra LifeSciences, among others.

Market Overview:

The pharmaceutical and healthcare sector is rapidly expanding in terms of revenue in the recent years and is expected to register robust CAGR over the forecast period of 2028. Factors such as rapid advancements in the pharma and healthcare sector, adoption of latest technologies, tools and equipment, emergence of various new diseases and improvements in healthcare facilities and infrastructure. In addition, rising healthcare expenditure, increasing per capita income in the developing countries and favorable reimbursement policies are fueling market growth. Increasing funds by various public and private sectors and increasing investments to develop enhanced products and devices are also boosting market growth. Moreover, increasing preference for ambulatory services and point of care services, and increasing funds for research centers and hospitals for drug discovery is expected to fuel market growth going ahead.

Competitive Landscape:

The report provides details about competitive landscape of global Liquid Embolic market focusing on every market player, its global position, revenue generation product portfolio, company overview, financial planning and business expansion plans. The global Liquid Embolic market is quite competitive and comprises various key players at global and regional levels. Key players are investing in research and development activities, and strategizing various plans such as mergers and acquisitions, partnerships, joint ventures, new product launches, to enhance their product base and strengthen their market position.

Grab Your Report at an Impressive Discount! Please Click Here: https://www.reportsanddata.com/discount-enquiry-form/2690

Further key findings from the report suggest

• Brain Arteriovenous Malformations is the tangle of abnormal blood vessels that connect veins and arteries in the brain. They can develop anywhere in the body and but occurs generally in the spine or brain. The disease are rare and affects less than one percent of the population.

• Hospitals held a major market share as these sophisticated devices are available in bigger hospitals and critical care units. The increasing adoption of minimally invasive surgeries, increase in the purchasing power, and investment into the healthcare sector is boosting the growth of the market.

• Sodium Morrhuate is consumed mainly by injection and is a mixture of salts of the saturated and unsaturated fatty acids of cod liver oil. It is a pale yellow, granular powder with a slight fishy odor and is soluble in water and alcohol.

• North America held the largest market share due to the availability of advanced equipment and quicker adoption of innovative surgeries. The region also invest in research and development heavily.

• The U.S. is the largest market for liquid embolic products. The growth of the market forecasts estimate that the major share of liquid embolic sales are related to the products for the treatment of approved neurovascular indications. However, primary research suggests that off-label usage of liquid embolic agents accounts for a significant percentage of overall utilization.

To know more about the report @ https://www.reportsanddata.com/report-detail/liquid-embolic-market

For the purpose of this report, Reports and Data have segmented into the global Liquid Embolic market on the basis of product, application, end-users, and region:

Product Outlook (Revenue, USD Billion; 2016-2027)

• Isobutyl-2-Cyanoacrylate(IBCA)
• Sodium Morrhuate
• Ethanol
• Bletilla Striata

Application Outlook (Revenue, USD Billion; 2016-2027)

• Brain Arteriovenous Malformations
• Tumor and Brain Cancer
• Brain Aneurysm
• Ischemic Stroke

End Users Outlook (Revenue, USD Billion; 2016-2027)

• Hospitals
• Ambulatory Surgical Centers

Regional Outlook:

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
• Asia Pacific (China, India, Japan, South Korea, Rest of APAC)
• Latin America (Brazil, Rest of LATAM)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2690

Thank you for reading the research report. We also provide report customization as per client request. Kindly contact us to know more about this customization feature and our team will offer you with the best suited report.

Browse More Reports:

Trauma Products Market @ https://www.medgadget.com/2021/10/trauma-products-market-expected-to-reach-usd-9-41-billion-in-2028-increasing-geriatric-population-prevalence-of-degenerative-bone-diseases-such-as-osteoarthritis-rheumatoid-arthritis-rn.html

Digital Health Market @ https://www.medgadget.com/2021/10/digital-health-market-expected-to-reach-usd-328-48-billion-in-2028-increasing-preference-for-personalized-medicines-adoption-of-mhealth-technology-rnd.html

Dietary Supplements Market @ https://www.medgadget.com/2021/10/dietary-supplements-market-expected-to-reach-usd-239-46-billion-in-2028-major-prevalence-of-lifestyle-diseases-is-the-key-factor-driving-market-growth-rnd.html

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Tushar Rajput
Reports and Data
+18008193052 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.